Aliment Pharmacol Ther

1. VASUDEVAN A, Con D, van Langenberg DR
   Letter: Thioguanine, an under-utilised option in inflammatory bowel disease? Authors' reply.
   Aliment Pharmacol Ther. 2024;59:1011.
   

   >> Share

   
   
2. ASONUMA K, Sagami S, Kobayashi T
   Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights.
   Aliment Pharmacol Ther. 2024;59:1005-1006.
   

   >> Share

   
   
3. CHETWOOD JD, Paramsothy S, Leong RW
   Letter: Thioguanine, an underutilised option in inflammatory bowel disease?
   Aliment Pharmacol Ther. 2024;59:1009-1010.
   

   >> Share

   
   

   
   BMC Gastroenterol

4. PEYRIN-BIROULET L, Arkkila P, Armuzzi A, Danese S, et al
   Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials.
   BMC Gastroenterol. 2024;24:121.
   

   >> Share

   
   

   
   Dig Dis Sci

5. VEGA P, Huguet JM, Gomez E, Rubio S, et al
   IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management.
   Dig Dis Sci. 2024;69:749-765.
   

   >> Share

   
   
6. STALLMACH A, Grunert PC
   Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies.
   Dig Dis Sci. 2024;69:657-659.
   

   >> Share

   
   
7. KOCHAR B, Rusher A, Araka E, Glasser R, et al
   Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases.
   Dig Dis Sci. 2024;69:766-774.
   

   >> Share

   
   
8. KELLAR A, Dolinger MT, Spencer EA, Dubinsky MC, et al
   Real-World Outcomes of Dual Advanced Therapy in Children and Young Adults with Inflammatory Bowel Disease.
   Dig Dis Sci. 2024 Mar 23. doi: 10.1007/s10620-024-08379.
   

   >> Share

   
   
9. CARVALHAS GABRIELLI AM, Ferretti F, Monico CM, Tombetti E, et al
   Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study.
   Dig Dis Sci. 2024 Mar 26. doi: 10.1007/s10620-024-08394.
   

   >> Share

   
   

   
   Eur J Gastroenterol Hepatol

10. ZAGOROWICZ E, Binowski G, Strzadala D, Pruszko C, et al
    Savings in social expenditures for work incapacity in patients with inflammatory bowel disease depend on access to innovative therapies in Poland.
    Eur J Gastroenterol Hepatol. 2024 Mar 19. doi: 10.1097/MEG.0000000000002764.
    

    >> Share

    
    

    
    Gastroenterol Hepatol

11. FUENTES-VALENZUELA E, Carbajo AY, Fernandez-Prada SJ, Rubiales BM, et al
    Beyond Crohn's disease: Deferasirox as possible agent for drug-induced ileocolitis.
    Gastroenterol Hepatol. 2024;47:380-381.
    

    >> Share

    
    
12. RODRIGUEZ-LAGO I, Abecia L, Seoane I, Anguita J, et al
    An in vitro analysis of the interaction between infliximab and granulocyte-monocyte apheresis.
    Gastroenterol Hepatol. 2024;47:347-351.
    

    >> Share

    
    

    
    Inflamm Bowel Dis

13. BASTON-REY I, Rodriguez-Lago I, Luque AM, Caballol B, et al
    The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU.
    Inflamm Bowel Dis. 2024 Mar 22:izae041. doi: 10.1093.
    

    >> Share

    
    
14. GARCIA-MATEO S, Martinez-Dominguez SJ, Gargallo-Puyuelo CJ, Gallego B, et al
    Healthy Lifestyle Is a Protective Factor from Moderate and Severe Relapses and Steroid Use in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2024 Mar 23:izae062. doi: 10.1093.
    

    >> Share

    
    
15. SHAHUB S, Kumar RM, Lin KC, Banga I, et al
    Continuous Monitoring of CRP, IL-6, and Calprotectin in Inflammatory Bowel Disease Using a Perspiration-Based Wearable Device.
    Inflamm Bowel Dis. 2024 Mar 23:izae054. doi: 10.1093.
    

    >> Share

    
    
16. POSNER H, Lombard R, Akiyama S, Cohen NA, et al
    Extensive Disease and Exposure to Multiple Biologics Precolectomy Is Associated with Endoscopic Cuffitis Post-Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2024 Mar 23:izae029. doi: 10.1093.
    

    >> Share

    
    
17. OLIVA S, Veraldi S, Russo G, Aloi M, et al
    Pan-enteric Capsule Endoscopy to Characterize Crohn's Disease Phenotypes and Predict Clinical Outcomes in Children and Adults: The Bomiro Study.
    Inflamm Bowel Dis. 2024 Mar 26:izae052. doi: 10.1093.
    

    >> Share

    
    
18. YARUR AJ, Ungaro R, Huang K, Wang W, et al
    Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium.
    Inflamm Bowel Dis. 2024 Mar 26:izae058. doi: 10.1093.
    

    >> Share

    
    
19. BOHRA A, Batt N, Dutt K, Sluka P, et al
    Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment?
    Inflamm Bowel Dis. 2024 Mar 27:izae069. doi: 10.1093.
    

    >> Share

    
    
20. BERNSTEIN CN, Panaccione R, Nugent Z, Marshall DA, et al
    Crohn's Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study.
    Inflamm Bowel Dis. 2024 Mar 27:izae055. doi: 10.1093.
    

    >> Share

    
    
21. HASHASH JG, Yu Ci Ng F, Farraye FA, Wang Y, et al
    Inter- and Intraobserver Variability on Endoscopic Scoring Systems in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2024 Mar 28:izae051. doi: 10.1093.
    

    >> Share

    
    
22. COLMAN RJ, Solitano V, MacDonald JK, Ma C, et al
    Operating Properties of Disease Activity Indices in Pediatric Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2024 Mar 28:izae060. doi: 10.1093.
    

    >> Share

    
    

    
    J Crohns Colitis

23. VAN DEN HOUTE M, Guadagnoli L, Ohman L, Bergstedt A, et al
    Predictors of symptom trajectory in newly diagnosed ulcerative colitis: a 3-year follow-up cohort study.
    J Crohns Colitis. 2024 Mar 29:jjae046. doi: 10.1093.
    

    >> Share

    
    
24. CUNHA MF, Roseira J
    Letter to the Editor regarding the article Minimally invasive surgery for Inflammatory Bowel Disease: a systematic review and meta-analysis of robotic versus laparoscopic surgical techniques.
    J Crohns Colitis. 2024 Mar 28:jjae045. doi: 10.1093.
    

    >> Share

    
    
25. SCIBERRAS M, Farrugia Y, Gordon H, Furfaro F, et al
    Accuracy of Information given by ChatGPT for patients with Inflammatory Bowel Disease in relation to ECCO Guidelines.
    J Crohns Colitis. 2024 Mar 23:jjae040. doi: 10.1093.
    

    >> Share

    
    
26. SHRESTHA S, Brand JS, Osooli M, Eriksson C, et al
    Spondyloarthritis in first-degree relatives and spouses of patients with inflammatory bowel disease: A nationwide population-based cohort study from Sweden.
    J Crohns Colitis. 2024 Mar 22:jjae041. doi: 10.1093.
    

    >> Share

    
    

    
    J Pediatr

27. LERCHOVA T, Stordal K, Andersson B, Ludvigsson J, et al
    Atopic Dermatitis in Early Childhood and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study.
    J Pediatr. 2024 Mar 21:114027. doi: 10.1016/j.jpeds.2024.114027.
    

    >> Share

    
    

    
    PLoS One

28. OCAMPO YC, Castro JP, Pajaro IB, Caro D, et al
    Protective effect of sucrose esters from cape gooseberry (Physalis peruviana L.) in TNBS-induced colitis.
    PLoS One. 2024;19:e0299687.
    

    >> Share

    
    
29. TORRES-HUERTA A, Ruley-Haase K, Reed T, Boger-May A, et al
    Retinoid orphan receptor gamma t (rorgammat) promotes inflammatory eosinophilia but is dispensable for innate immune-mediated colitis.
    PLoS One. 2024;19:e0300892.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share